Approval · Notice of Compliance 35136 · 2025
APRI 21: Notice of Compliance 35136
Issued April 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35136
- Date
- April 4, 2025
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph
- Canadian reference product
- MARVELON (Organon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APRI 21 | Not yet assigned | — |
| APRI 28 | Not yet assigned | — |
Medicinal ingredients
- DESOGESTREL 0.15 MG per TAB
- ETHINYL ESTRADIOL 0.03 MG per TAB